Meta-analysis of association between obsessive-compulsive disorder and the 3′ region of neuronal glutamate transporter gene SLC1A1

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 4, 2013, Pages 367-379

  Stewart, S E ^a,b,c,d,e   Mayerfeld, C ^b   Arnold, P D ^f,g   Crane, J R ^b   O'Dushlaine, C ^h   Fagerness, J A ^b   Yu, D ^b   Scharf, J M ^b,c,h   Chan, E ^d   Kassam, F ^d   Moya, P R ⁱ   Wendland, J R ^i,j   Delorme, R ^k,l,m   Richter, M A ^g,n   Kennedy, J L ^g,o   Veenstra Vanderweele, J ^p   Samuels, J ^q   Greenberg, B D ^r   Mccracken, J T ^s   Knowles, J A ^t   Fyer, A J ^u   Rauch, S L ^a,b,v   Riddle, M A ^q   Grados, M A ^q   Bienvenu, O J ^q   Cullen, B ^q   Wang, Y ^q   Shugart, Y Y ⁱ   Piacentini, J ^s   Rasmussen, S ^q   Nestadt, G ^q   Murphy, D L ⁱ   Jenike, M A ^a,b,c   Cook, E H ^w   Pauls, D L ^b,c   Hanna, G L ^x   Mathews, C A ^y   more..

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e British Columbia Mental Health and Addictions Research Institute Vancouver   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h BROAD INSTITUTE OF MIT AND HARVARD   (United States)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^j F HOFFMANN LA ROCHE LTD   (Switzerland)

^k HÔPITAL ROBERT DEBRÉ   (France)

^l INSERM U955   (France)

^m Fondation FondaMental French National Science Foundation   (France)

ⁿ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^o CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^p VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^q JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r BUTLER HOSPITAL   (United States)

^s UNIVERSITY OF CALIFORNIA   (United States)

^t UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^u Keck School of Medicine University of Southern California ^*  (United States)

^v Psychiatry and Mental Health   (United States)

^w UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^x UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^y UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Candidate gene; Glutamate; Meta analysis; Obsessive compulsive disorder; OCD; SLC1A1

Indexed keywords

EXCITATORY AMINO ACID TRANSPORTER 3;

ARTICLE; CASE CONTROL STUDY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; META ANALYSIS; OBSESSIVE COMPULSIVE DISORDER; PRIORITY JOURNAL; SAMPLE SIZE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

AMINO ACID TRANSPORT SYSTEM X-AG; CASE-CONTROL STUDIES; FEMALE; GENETIC MARKERS; HUMANS; MALE; NEURONS; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84878214704     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32137     Document Type: Article

References (89)

1. Aboujaoude E, Barry JJ, Gamel N. 2009. Memantine augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial. J Clin Psychopharmacol 29(1):51-55.
2. American Psychiatric Association. 2000. Diagnostic criteria from DSM-IV-TR. Washington, D.C: American Psychiatric Association. Vol. xii, p 370.
3. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL. 2006. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 63(7):760-769.
4. Bacanu SA. 2012. On optimal gene-based analysis of genome scans. Genet Epidemiol 36(4):333-339.
5. Bailey CG, Ryan RM, Thoeng AD, Ng C, King K, Vanslambrouck JM, Auray-Blais C, Vandenberg RJ, Bröer S, Rasko JE. 2011. Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria. J Clin Invest 121(1):446-453.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265.
7. Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. 1999. Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry 14(8):434-441.
8. Cavallini MC, Pasquale L, Bellodi L, Smeraldi E. 1999. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet 88(1):38-43.
9. Chakrabarty K, Bhattacharyya S, Christopher R, Khanna S. 2005. Glutamatergic dysfunction in OCD. Neuropsychopharmacology 30(9):1735-1740.
10. Cichon S, Craddock N, Daly M, Faraone SV, Gejman PV, Kelsoe J, Lehner T, Levinson DF, Moran A, Sklar P, Sullivan PF. 2009. Genomewide association studies: History, rationale, and prospects for psychiatric disorders. Am J Psychiatry 166(5):540-556.
11. Consortium MDDWGotPG. 2012. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry Epub ahead of print.
12. Coric V, Taskiran S, Pittenger C, Wasylink S, Mathalon DH, Valentine G, Saksa J, Wu YT, Gueorguieva R, Sanacora G, Malison RT, Krystal JH. 2005. Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial. Biol Psychiatry 58(5):424-428.
13. de Bakker PI, Ferreira MA, Jia X, Neale BM, Raychaudhuri S, Voight BF. 2008. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 17(R2):R122-R128.
14. Dickel DE, Veenstra-VanderWeele J, Cox NJ, Wu X, Fischer DJ, Van Etten-Lee M, Himle JA, Leventhal BL, Cook EH Jr, Hanna GL. 2006. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry 63(7):778-785.
15. Fischer DJ, Himle JA, Hanna GL. 1996. Age and gender effects on obsessive-compulsive symptoms in children and adults. Depress Anxiety 4(5):237-239.
16. Geller DA, Biederman J, Griffin S, Jones J, Lefkowitz TR. 1996. Comorbidity of juvenile obsessive-compulsive disorder with disruptive behavior disorders. J Am Acad Child Adolesc Psychiatry 35(12):1637-1646.
17. Grados M, Wilcox HC. 2007. Genetics of obsessive-compulsive disorder: A research update. Expert Rev Neurother 7(8):967-980.
18. Grant P, Lougee L, Hirschtritt M, Swedo SE. 2007. An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol 17(6):761-767.
19. Hanna GL, Fingerlin TE, Himle JA, Boehnke M. 2005a. Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Hum Hered 60(1):1-9.
20. Hanna GL, Fischer DJ, Chadha KR, Himle JA, Van Etten M. 2005b. Familial and sporadic subtypes of early-onset obsessive-compulsive disorder. Biol Psychiatry 57(8):895-900.
21. Hanna GL, Veenstra-VanderWeele J, Cox NJ, Boehnke M, Himle JA, Curtis GC, Leventhal BL, Cook EH Jr. 2002. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet 114(5):541-552.
22. Hanna GL, Veenstra-Vanderweele J, Cox NJ, Van Etten M, Fischer DJ, Himle JA, Bivens NC, Wu X, Roe CA, Hennessy KA, Dickel DE, Leventhal BL, Cook EH. 2007. Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol Psychiatry 62(8):856-862.
23. Hemmings SM, Stein DJ. 2006. The current status of association studies in obsessive-compulsive disorder. Psychiatr Clin North Am 29(2):411-444.
24. Huang H, Chanda P, Alonso A, Bader JS, Arking DE. 2011. Gene-based tests of association. PLoS Genet 7(7):e1002177.
25. Infante-Rivard C, Mirea L, Bull SB. 2009. Combining case-control and case-trio data from the same population in genetic association analyses: Overview of approaches and illustration with a candidate gene study. Am J Epidemiol 170(5):657-664.
26. Inouye E. 1965. Similar and dissimilar manifestations of obsessive-compulsive neuroses in monozygotic twins. Am J Psychiatry 121:1171-1175.
27. Ivarsson T, Melin K, Wallin L. 2008. Categorical and dimensional aspects of co-morbidity in obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry 17(1):20-31.
28. Kanai Y, Hediger MA. 2004. The glutamate/neutral amino acid transporter family SL C1: Molecular, physiological and pharmacological aspects. Pflugers Arch 447(5):469-479.
29. Karno M, Golding JM, Sorenson SB, Burnam MA. 1988. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 45(12):1094-1099.
30. Kazeem GR, Farrall M. 2005. Integrating case-control and TDT studies. Ann Hum Genet 69(Pt 3):329-335.
31. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. 2005. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62(6):617-627.
32. Kwon JS, Joo YH, Nam HJ, Lim M, Cho EY, Jung MH, Choi JS, Kim B, Kang DH, Oh S, Park T, Hong KS. 2009. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry 66(11):1233-1241.
33. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36-S42.
34. Lambert JC, Grenier-Boley B, Harold D, Zelenika D, Chouraki V, Kamatani Y, Sleegers K, Ikram MA, Hiltunen M, Reitz C, Mateo I, Feulner T, Bullido M, Galimberti D, Concari L, Alvarez V, Sims R, Gerrish A, Chapman J, Deniz-Naranjo C, Solfrizzi V, Sorbi S, Arosio B, Spalletta G, Siciliano G, Epelbaum J, Hannequin D, Dartigues JF, Tzourio C, Berr C, Schrijvers EM, Rogers R, Tosto G, Pasquier F, Bettens K, Van Cauwenberghe C, Fratiglioni L, Graff C, Delepine M, Ferri R, Reynolds CA, Lannfelt L, Ingelsson M, Prince JA, Chillotti C, Pilotto A, Seripa D, Boland A, Mancuso M, Bossù P, Annoni G, Nacmias B, Bosco P, Panza F, Sanchez-Garcia F, Del Zompo M, Coto E, Owen M, O'Donovan M, Valdivieso F, Caffara P, Scarpini E, Combarros O, Buée L, Campion D, Soininen H, Breteler M, Riemenschneider M, Van Broeckhoven C, Alpérovitch A, Lathrop M, Trégouët DA, Williams J, Amouyel P. 2012. Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry Epub ahead of print.
35. Lange C, DeMeo D, Silverman EK, Weiss ST, Laird NM. 2004. PBAT: Tools for family-based association studies. Am J Hum Genet 74(2):367-369.
36. Langley AK, Lewin AB, Bergman RL, Lee JC, Piacentini J. 2010. Correlates of comorbid anxiety and externalizing disorders in childhood obsessive compulsive disorder. Eur Child Adolesc Psychiatry 19(8):637-645.
37. Lensi P, Cassano GB, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. 1996. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 169(1):101-107.
38. Liang KY, Wang Y, Shugart YY, Grados M, Fyer AJ, Rauch S, Murphy D, McCracken J, Rasmussen S, Cullen B, Hoehn-Saric R, Greenberg B, Pinto A, Knowles J, Piacentini J, Pauls D, Bienvenu O, Riddle M, Samuels J, Nestadt G. 2008. Evidence for potential relationship between SLC1A1 and a putative genetic linkage region on chromosome 14q to obsessive-compulsive disorder with compulsive hoarding. Am J Med Genet Part B 147B(6):1000-1002.
39. Lin DY, Zeng D. 2010. Meta-analysis of genome-wide association studies: No efficiency gain in using individual participant data. Genet Epidemiol 34(1):60-66.
40. Mah AK. 2010. SLITRK5, a protein that links striatal deficits to OCD-like behaviours in mice. Clin Genet 78(4):350-352.
41. Mataix-Cols D, Rosario-Campos MC, Leckman JF. 2005. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 162(2):228-238.
42. Mathews CA, Badner JA, Andresen JM, Sheppard B, Himle JA, Grant JE, Williams KA, Chavira DA, Azzam A, Schwartz M, Reus VI, Kim SW, Cook EH, Hanna GL. 2012. Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36. Biol Psychiatry 72(8):629-636.
43. Matsunaga H, Kiriike N, Matsui T, Miyata A, Iwasaki Y, Fujimoto K, Kasai S, Kojima M. 2000. Gender differences in social and interpersonal features and personality disorders among Japanese patients with obsessive-compulsive disorder. Compr Psychiatry 41(4):266-272.
44. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. 2008. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: The orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32(3):525-549.
45. Nestadt G, Grados M, Samuels JF. 2010. Genetics of obsessive-compulsive disorder. Psychiatr Clin North Am 33(1):141-158.
46. Nestadt G, Lan T, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, Hoehn-Saric R, Cullen B, Grados M, Beaty TH, Shugart YY. 2000a. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet 67(6):1611-1616.
47. Nestadt G, Samuels J, Riddle M, Bienvenu OJ III, Liang KY, LaBuda M, Walkup J, Grados M, Hoehn-Saric R. 2000b. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 57(4):358-363.
48. Nicodemus KK. 2008. Catmap: Case-control and TDT meta-analysis package. BMC Bioinformatics 9:130.
49. Nicolini H, Arnold P, Nestadt G, Lanzagorta N, Kennedy JL. 2009. Overview of genetics and obsessive-compulsive disorder. Psychiatry Res 170(1):7-14.
50. Pato MT, Pato CN, Pauls DL. 2002. Recent findings in the genetics of OCD. J Clin Psychiatry 63(Suppl 6):30-33.
51. Pittenger C, Bloch MH, Williams K. 2011. Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment. Pharmacol Ther 132(3):314-332.
52. Pittenger C, Krystal JH, Coric V. 2006. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder. NeuroRx 3(1):69-81.
53. Purcell S, Cherny SS, Sham PC. 2003. Genetic power calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19(1):149-150.
54. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
55. Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ. 1994. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51(1):62-70.
56. Ravizza L, Maina G, Bogetto F. 1997. Episodic and chronic obsessive-compulsive disorder. Depress Anxiety 6(4):154-158.
57. Risch NJ. 2000. Searching for genetic determinants in the new millennium. Nature 405(6788):847-856.
58. Rosenberg DR, Mirza Y, Russell A, Tang J, Smith JM, Banerjee SP, Bhandari R, Rose M, Ivey J, Boyd C, Moore GJ. 2004. Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls. J Am Acad Child Adolesc Psychiatry 43(9):1146-1153.
59. Ross J, Badner J, Garrido H, Sheppard B, Chavira DA, Grados M, Woo JM, Doo P, Umaña P, Fournier E, Murray SS, Mathews CA. 2011. Genomewide linkage analysis in Costa Rican families implicates chromosome 15q14 as a candidate region for OCD. Hum Genet 130(6):795-805.
60. Sampaio AS, Fagerness J, Crane J, Leboyer M, Delorme R, Pauls DL, Stewart SE. 2011. Association between polymorphisms in GRIK2 gene and obsessive-compulsive disorder: A family-based study. CNS Neurosci Ther 17(3):141-147.
61. Samuels J, Wang Y, Riddle MA, Greenberg BD, Fyer AJ, McCracken JT, Rauch SL, Murphy DL, Grados MA, Knowles JA, Piacentini J, Cullen B, Bienvenu OJ III, Rasmussen SA, Geller D, Pauls DL, Liang KY, Shugart YY, Nestadt G. 2011. Comprehensive family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder. Am J Med Genet Part B 156B(4):472-477.
62. Saxena S, Rauch SL. 2000. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 23(3):563-586.
63. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. 2006a. Genomewide linkage scan for obsessive-compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11(8):763-770.
64. Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G. 2006b. Genomewide linkage scan for obsessive-compulsive disorder: Evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 11(8):763-770.
65. Shugart YY, Wang Y, Samuels JF, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen B, Hoehn-Saric R, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Bienvenu OJ, Riddle MA, Liang KY, Nestadt G. 2009. A family-based association study of the glutamate transporter gene SLC1A1 in obsessive-compulsive disorder in 378 families. Am J Med Genet Part B 150B(6):886-892.
66. Smith CP, Weremowicz S, Kanai Y, Stelzner M, Morton CC, Hediger MA. 1994. Assignment of the gene coding for the human high-affinity glutamate transporter EAAC1 to 9p24: Potential role in dicarboxylic aminoaciduria and neurodegenerative disorders. Genomics 20(2):335-336.
67. Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL. 2007a. Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder. Am J Med Genet Part B 144B(8):1027-1033.
68. Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA. 2010. A single-blinded case-control study of memantine in severe obsessive-compulsive disorder. J Clin Psychopharmacol 30(1):34-39.
69. Stewart SE, Rosario MC, Baer L, Carter AS, Brown TA, Scharf JM, Illmann C, Leckman JF, Sukhodolsky D, Katsovich L, Rasmussen S, Goodman W, Delorme R, Leboyer M, Chabane N, Jenike MA, Geller DA, Pauls DL. 2008. Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 47(7):763-772.
70. Stewart SE, Rosario MC, Brown TA, Carter AS, Leckman JF, Sukhodolsky D, Katsovitch L, King R, Geller D, Pauls DL. 2007b. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry 61(3):285-291.
71. Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Edlund CK, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MA, Cook EH, Kennedy JL, Rosenberg D, Stein DJ, Hemmings SM, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra-Vanderweele J, Denys D, Blom R, Deforce D, Van Nieuwerburgh F, Westenberg HG, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do, Rosário M, Sampaio AS, Vallada H, Nicolini H, Lanzagorta N, Camarena B, Delorme R, Leboyer M, Pato CN, Pato MT, Voyiaziakis E, Heutink P, Cath DC, Posthuma D, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Coric V, Leckman JF, Bloch M, Pittenger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Cookson MR, Singleton A, Hardy J, Crenshaw AT, Parkin MA, Mirel DB, Conti DV, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL, Consortium ftNABE, Database ftUBE. 2012. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry Epub ahead of print.
72. Swedo SE, Schapiro MB, Grady CL, Cheslow DL, Leonard HL, Kumar A, Friedland R, Rapoport SI, Rapoport JL. 1989. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Arch Gen Psychiatry 46(6):518-523.
73. Taylor S. 2012. Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies. Mol Psychiatry Epub ahead of print.
74. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. 2008. Meta-analysis methods. Adv Genet 60:311-334.
75. Tukel R, Polat A, Genc A, Bozkurt O, Atli H. 2004. Gender-related differences among Turkish patients with obsessive-compulsive disorder. Compr Psychiatry 45(5):362-366.
76. van Grootheest DS, Cath DC, Beekman AT, Boomsma DI. 2005. Twin studies on obsessive-compulsive disorder: A review. Twin Res Hum Genet 8(5):450-458.
77. Veenstra-VanderWeele J, Kim SJ, Gonen D, Hanna GL, Leventhal BL, Cook EH Jr. 2001. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Mol Psychiatry 6(2):160-167.
78. Veenstra-VanderWeele J, Xu T, Ruggiero AM, Anderson LR, Jones ST, Himle JA, Kennedy JL, Richter MA, Hanna GL, Arnold PD. 2012. Functional studies and rare variant screening of SLC1A1/EAAC1 in males with obsessive-compulsive disorder. Psychiatr Genet 22(5):256-260.
79. Walitza S, Wendland JR, Gruenblatt E, Warnke A, Sontag TA, Tucha O, Lange KW. 2010. Genetics of early-onset obsessive-compulsive disorder. Eur Child Adolesc Psychiatry 19(3):227-235.
80. Wang Y, Adamczyk A, Shugart YY, Samuels JF, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Rasmussen SA, Cullen B, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Bienvenu OJ, Riddle M, Liang KY, Valle D, Wang T, Nestadt G. 2010. A screen of SLC1A1 for OCD-related alleles. Am J Med Genet Part B 153B(2):675-679.
81. Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wickramaratne PJ, et al. 1994. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry (Suppl 55):5-10.
82. Welch JM, Lu J, Rodriguiz RM, Trotta NC, Peca J, Ding JD, Feliciano C, Chen M, Adams JP, Luo J, Dudek SM, Weinberg RJ, Calakos N, Wetsel WC, Feng G. 2007. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature 448(7156):894-900.
83. Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, Ren-Patterson RF, Murphy DL. 2009. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 66(4):408-416.
84. Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. 2006. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res 146(2):137-147.
85. Willour VL, Yao Shugart, Samuels Y, Grados J, Cullen M, Bienvenu B, Wang OJ III, Liang Y, Valle KY, Hoehn-Saric D, Riddle R, Nestadt MG. 2004a. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet 75(3):508-513.
86. Willour VL, Yao Shugart Y, Samuels J, Grados M, Cullen B, Bienvenu OJ, Wang Y, Liang KY, Valle D, Hoehn-Saric R, Riddle M, Nestadt G. 2004b. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder. Am J Hum Genet 75(3):508-513.
87. Wu K, Hanna GL, Rosenberg DR, Arnold PD. 2012. The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder. Pharmacol Biochem Behav 100(4):726-735.
88. Yucel M, Wood SJ, Wellard RM, Harrison BJ, Fornito A, Pujol J, Velakoulis D, Pantelis C. 2008. Anterior cingulate glutamate-glutamine levels predict symptom severity in women with obsessive-compulsive disorder. Aust N Z J Psychiatry 42(6):467-477.
89. Zohar J, Gross-Isseroff R, Hermesh H, Weizman A. 1999. Is there sexual dimorphism in obsessive-compulsive disorder? Neurosci Biobehav Rev 23(6):845-849.